Mangoceuticals Inc

Mangoceuticals Inc

MGRX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.19M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mangoceuticals IncMangoceuticals Inc-0.2--121%--
$-0.32

Current Fair Value

238.9% downside

Overvalued by 238.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.19 Million
Enterprise Value$5.28 Million
Earnings per Share$-2.17
Beta1.98
Outstanding Shares17,119,619

Return

Return on Equity-120.58%ROE
Return on Assets-106.57%
Return on Invested Capital-95.67%

Valuation & Multiples

P/E Ratio-0.2P/E Ratio
PEG0.26PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue32.21
Enterprise Value to EBIT-0.43
Enterprise Value to Net Income-1
Total Debt to Enterprise0.06
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.20%▼ 6.85%
Total Invested$14,769▼ 96.78%
Investors Holding1▼ 18.00%

About Mangoceuticals Inc

Mangoceuticals Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.